Vitro Diagnostics, Inc. (OTCQB:VODG)

Vitro Diagnostics dba Vitro Biopharma develops and commercialize adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. We offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells (MSCs).

Company Information

Vitro Biopharma
4621 Technology Drive
Golden, CO 80403
303-999-2130
www.vitrobiopharma.com

Investor Relations

Jim Musick
CEO & President
jim@vitrobiopharma.com
(303) 999-2130 Ext.3
wwww.vitrobiopharma.com

Transfer Agent

Securities Transfer Corporation
2591 Dallas Parkway, Suite 102
Frisco, TX 75034
469-633-0100
www.stctransfer.com

Share Statistics

Outstanding: 19,308,912

(As of September 14, 2012)

VODG 0.0813 0.00 %

SEC Filings

Filing Date Description
March 21, 2012 1st Quarter 2012 [XBRL]
February 16, 2012 Annual Report 2011 [XBRL]
October 12, 2011 Third Quarter 2011 [XBRL]

Click here to view older SEC Filings.

Daily Stock Price View

Weekly Stock Price View

Current Financial Information

Historical Quotes

Information Request

Looking for Additional Information? Please visit our Frequently Asked Questions. Or contact our team by clicking below.

Click Here